Key result
Dabigatran etexilate has entered the European market as a medicine with an entirely new mechanism of action.
Design
Editorial
Authors
Loading...
Introduces dabigatran etexilate as a novel medication with a new mechanism of action entering the European market.
Introduces dabigatran etexilate as a novel medication with a new mechanism of action entering the European market.
Dubois et al. (2010) studied this question. Dabigatran etexilate has entered the European market as a medicine with an entirely new mechanism of action.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: